Clinical Trial Update: Conjugated Linoleic Acid and Atherosclerosis [Phase 3]

View source ↗

Summary

A Phase 3 trial of conjugated linoleic acid for atherosclerosis has completed. The update does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Conjugated Linoleic Acid (Conjugated linoleic acid)

Snippet

Sponsor: UMC Utrecht | Conditions: Atherosclerosis | Phase 3 | Status: COMPLETED